Low v. Pfizer Inc. et al.
Back to all cases
Counsel to Pfizer in a proposed class action advanced on behalf of consumers of Viagra. The plaintiff claimed that Pfizer had secured its patent for Viagra unlawfully, and as a result had overcharged purchasers. The BC Court of Appeal denied certification and dismissed the action, on the basis that the legislative scheme for patents is a “complete code” and does not permit right of action beyond those contemplated in the legislation. 2015 BCCA 506